Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Brunet, L. Pare
63  Ergebnisse:
Personensuche X
?
1

12P Updated findings from the first prospective HER2DX clin..:

Martínez-Sáez, O. ; Marin, M. ; Hernández-Illán, E....
ESMO Open.  9 (2024)  - p. 103021 , 2024
Link: https://doi.org/10.1016/..
 
?
2

49P A ctDNA tool for identifying ESR1-mutated biology in ES..:

Fructuoso, I. Garcia ; Martínez-Sáez, O. ; Pardo, F....
ESMO Open.  9 (2024)  - p. 103056 , 2024
Link: https://doi.org/10.1016/..
 
?
3

1MO HER2DX assay and survival outcomes: An individual-patie..:

Javierre, G. Villacampa ; Cortés, J. ; García, J.M. Pérez...
ESMO Open.  9 (2024)  - p. 103011 , 2024
Link: https://doi.org/10.1016/..
 
?
4

14P Assessing the predictive value of HER2DX pCR-score for ..:

Martínez-Sáez, O. ; Marin, M. ; Brunet, L. Pare...
ESMO Open.  9 (2024)  - p. 103023 , 2024
Link: https://doi.org/10.1016/..
 
?
5

74P Assessing the implementation of the HER2DX genomic test..:

Cejalvo, J.M. ; Soberino, J. ; Ciruelos, E.M....
ESMO Open.  9 (2024)  - p. 103080 , 2024
Link: https://doi.org/10.1016/..
 
?
6

13P HER2DX ERBB2 mRNA score in first-line metastatic HER2-p..:

Bayona, R. Sanchez ; Martínez-Sáez, O. ; Romero, D.R....
ESMO Open.  9 (2024)  - p. 103022 , 2024
Link: https://doi.org/10.1016/..
 
?
7

8P Evaluating HER2DX pCR-Score and MRI response in predicti..:

Pascual, T. ; Martínez-Sáez, O. ; Brunet, L. Pare...
ESMO Open.  9 (2024)  - p. 103017 , 2024
Link: https://doi.org/10.1016/..
 
?
8

8P First decision impact study of HER2DX in patients (pts) ..:

Saez, O. Martinez ; Brasó-Maristany, F. ; Marín-Aguilera, M....
ESMO Open.  8 (2023)  1 - p. 101232 , 2023
Link: https://doi.org/10.1016/..
 
?
9

13P Analytical validation of HER2DX test for early-hER2+ br..:

Torres, E. Sanfeliu ; Marín-Aguilera, M. ; Jares, P....
ESMO Open.  8 (2023)  1 - p. 101237 , 2023
Link: https://doi.org/10.1016/..
 
?
10

12P HER2DX in HER2-positive (HER2+) inflammatory breast can..:

Lynce, F. ; Brasó-Maristany, F. ; Waks, A.G....
ESMO Open.  8 (2023)  1 - p. 101236 , 2023
Link: https://doi.org/10.1016/..
 
?
11

126MO HER2DX and pathological complete response in HER2-pos..:

Waks, A.G. ; Villacampa, G. ; Brunet, L. Pare...
ESMO Open.  8 (2023)  1 - p. 101465 , 2023
Link: https://doi.org/10.1016/..
 
?
12

5P HER2DX risk-score in HER2-positive (HER2+) breast cancer..:

Saez, O. Martinez ; Brasó-Maristany, F. ; Griguolo, G....
ESMO Open.  8 (2023)  1 - p. 101229 , 2023
Link: https://doi.org/10.1016/..
 
?
13

6P Combined analysis of the HER2DX genomic tool in adjuvant..:

Tarantino, P. ; Villacampa, G. ; Graham, N....
ESMO Open.  8 (2023)  1 - p. 101230 , 2023
Link: https://doi.org/10.1016/..
 
?
14

102P HER2DX risk-score in early-stage HER2-positive (HER2+)..:

Pascual, T. ; Villacampa, G. ; Brasó-Maristany, F....
ESMO Open.  8 (2023)  1 - p. 101326 , 2023
Link: https://doi.org/10.1016/..
 
?
15

11P Independent validation of the HER2DX assay in HER2-posi..:

Grimalt, B. Fullana ; Brasó-Maristany, F. ; Gómez, N....
ESMO Open.  8 (2023)  1 - p. 101235 , 2023
Link: https://doi.org/10.1016/..
 
1-15